Ngā kupu hautoa kōpae
Tohutoro APA (7th ed.)
K, D., D, T., F, E., M, L., M, K., B, R., & H, B. (2013). EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: Folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. Dove Medical Press.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoru Kātū Chicago (17th ed.)
K, Diefenbach, Trummer D, Ebert F, Lissy M, Koch M, Rohde B, me Blode H. EE-drospirenone-levomefolate Calcium Versus EE-drospirenone + Folic Acid: Folate Status During 24 Weeks of Treatment and over 20 Weeks Following Treatment Cessation. Dove Medical Press, 2013.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoro MLA (9th ed.)
K, Diefenbach, et al. EE-drospirenone-levomefolate Calcium Versus EE-drospirenone + Folic Acid: Folate Status During 24 Weeks of Treatment and over 20 Weeks Following Treatment Cessation. Dove Medical Press, 2013.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.